NEW YORK (GenomeWeb News) — A Wisconsin court has upheld a $7-million verdict against Abbott Laboratories for infringing a patent held by Innogenetics that protects a process for typing HCV isolates, the Belgian biotech said yesterday.

 

The court also denied Abbott’s motion for a new trial based on “infringement and validity” and granted Innogenetics’ motion to set another hearing to consider permanently barring Abbott from selling the infringing products, Innogenetics said.